Published in Am Psychol on October 01, 1971
Advancing the science of community-level interventions. Am J Public Health (2011) 2.86
Chronicity reconsidered: improving person-environment fit through a consumer-run service. Community Ment Health J (2001) 1.15
Introduction to ecological description of a community intervention: building prevention through collaborative field based research. Am J Community Psychol (2014) 0.76
Geography and personality: why do different neighborhoods have different vibes? Proc Natl Acad Sci U S A (2015) 0.75
Reflections on a Community Psychology Setting and the Future of the Field. Am J Community Psychol (2016) 0.75
Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker. Clin Pharmacol Ther (1976) 3.16
The clinical pharmacology of mexiletine. Br J Clin Pharmacol (1978) 2.56
Blood levels of practolol after oral and parenteral administration and their relationship to exercise heart rate. Clin Pharmacol Ther (1974) 1.81
Observations on the efficacy and pharmacokinetics of sotalol after oral administration. Eur J Clin Pharmacol (1976) 1.71
Mexiletine (Kö 1173) in the management of ventricular dysrhythmias. Lancet (1973) 1.68
Clinical pharmacokinetics of oral anticoagulants. Clin Pharmacokinet (1979) 1.66
Plasma digoxin concentrations in patients on admission to hospital. Br Heart J (1974) 1.46
Pharmacokinetics of enalapril in normal subjects and patients with renal impairment. Br J Clin Pharmacol (1986) 1.38
Spectrophotofluorometric and gas-liquid chromatographic methods for the estimation of mexiletine (Kö 1173) in plasma and urine. J Pharm Pharmacol (1973) 1.36
Duration of action of beta-blocking drugs. Br Med J (1973) 1.33
Measurement of theophylline in plasma by high performance liquid chromatography. Br J Clin Pharmacol (1976) 1.31
Measurement of plasma mexiletine concentrations. Postgrad Med J (1977) 1.28
Theophylline kinetics in relation to age: the importance of smoking. Br J Clin Pharmacol (1980) 1.23
Correlation of reduction of exercise heart rate with blood levels of atenolol after oral and intravenous administration. Postgrad Med J (1977) 1.13
The development of mexiletine in the management of ventricular dysrhythmias. Postgrad Med J (1977) 1.09
Do patients take digoxin? Br Heart J (1978) 1.06
Ecological constraints on mental health services. Am Psychol (1966) 1.00
Survey of medication documentation at hospital discharge: implications for patient safety and continuity of care. Ir J Med Sci (2008) 0.99
Beta-adrenoceptor adaptation to acute exercise. J Physiol (1983) 0.98
Clinical and pharmacokinetic properties of a transdermal nicotine patch. Clin Pharmacol Ther (1990) 0.98
Mexiletine in normal volunteers. Br J Clin Pharmacol (1978) 0.97
The excretion of enalapril and enalaprilat in human breast milk. Eur J Clin Pharmacol (1990) 0.97
Pharmacokinetics of low-dose methotrexate in children receiving maintenance therapy for acute lymphoblastic leukaemia. Cancer Chemother Pharmacol (1982) 0.94
Effects of thyroid dysfunction on propranolol kinetics. Clin Pharmacol Ther (1980) 0.92
Lymphocyte cyclic AMP production in the elderly: the effects of prostaglandin E1. Br J Clin Pharmacol (1981) 0.90
Radioreceptor assay for labetalol. Br J Clin Pharmacol (1981) 0.87
Cardiac sensitivity to isoprenaline, lymphocyte beta-adrenoceptors and age. Clin Sci (Lond) (1984) 0.87
Relationship of beta-adrenoreceptor density to fitness in athletes. Nature (1982) 0.86
Patient-controlled analgesia using a miniature electrochemically driven infusion pump. Br J Anaesth (1994) 0.86
Human lymphocyte beta-adrenoceptor density in relation to age and hypertension. J Cardiovasc Pharmacol (1982) 0.86
Plasma protein binding of propranolol and isoprenaline in hyperthyroidism and hypothyroidism. Br J Clin Pharmacol (1978) 0.85
Pharmacokinetics of a microcrystalline theophylline preparation in patients with chronic obstructive airways disease. Eur J Clin Pharmacol (1978) 0.83
Metabolic and cardiovascular effects of isoprenaline and salbutamol in the dog. Br J Pharmacol (1975) 0.82
Pharmacokinetics of digoxin in the elderly [proceedings]. Br J Clin Pharmacol (1978) 0.82
Adrenergic receptors in depression. Effects of electroconvulsive therapy. Br J Psychiatry (1985) 0.82
Studies of the effect of thyroid dysfunction on the elimination of beta-adrenoreceptor blocking drugs. Br J Clin Pharmacol (1977) 0.82
Effect of hydrochlorothiazide on the pharmacokinetics of enalapril in hypertensive patients with varying renal function. J Cardiovasc Pharmacol (1996) 0.81
Pharmacokinetics of digoxin alone and in the presence of indomethacin therapy. Br J Clin Pharmacol (1984) 0.81
Lisinopril population pharmacokinetics in elderly and renal disease patients with hypertension. Br J Clin Pharmacol (1989) 0.80
Adrenoceptors mediating metabolic responses in the greyhound. Br J Pharmacol (1971) 0.80
Effects of ranitidine on the disposition of metoprolol. Br J Clin Pharmacol (1985) 0.80
Naturalistic observations and theory confirmation: an example. Hum Dev (1967) 0.79
The clinical pharmacology of tolmesoxide. A new vasodilator antihypertensive agent. Eur J Clin Pharmacol (1982) 0.79
Antidotes for arrogance: training for community psychology. Am Psychol (1970) 0.79
Digoxin "receptors" in neonates: an explanation of less sensitivity to digoxin than in adults. Clin Pharmacol Ther (1980) 0.79
The pharmacokinetics of paroxetine in renal impairment. Acta Psychiatr Scand Suppl (1989) 0.79
Long term oral antiarrhythmic therapy with mexiletine. Postgrad Med J (1977) 0.79
Erythrocyte cation transport and age: effects of digoxin and furosemide. Clin Pharmacol Ther (1983) 0.79
The effect of age and smoking on theophylline kinetics [proceedings]. Br J Clin Pharmacol (1979) 0.79
Clinical pharmacology of tolmesoxide in refractory heart failure. Eur J Clin Pharmacol (1981) 0.78
Bioavailability of labetalol increases with age. Br J Clin Pharmacol (1982) 0.78
Comparison of the effects of lignocaine and mexiletine on experimental ventricular arrhythmias. Postgrad Med J (1977) 0.78
A comparison of plasma levels of theophyllinates after oral administration. Br J Clin Pharmacol (1976) 0.78
Personality typing and anxiety for two groups of registered nurses. Aust J Adv Nurs (1985) 0.77
Stress, coping behaviors, and recommendations for intensive care and medical surgical ward registered nurses. Res Nurs Health (1985) 0.77
Adrenoceptor status and cardiovascular function in ageing. J Hypertens Suppl (1988) 0.77
Antihypertensive and renal effects of lisinopril in older patients with hypertension. Am J Med (1988) 0.77
Plasma and tissue digoxin concentrations in patients undergoing cardiopulmonary bypass. Br Heart J (1975) 0.76
Actions of R- and S-verapamil and nifedipine on rat vascular and intestinal smooth muscle. Auton Autacoid Pharmacol (2004) 0.76
Observations on intravenous administration of lignocaine in patients with myocardial infarction. Br Heart J (1978) 0.75
Sodium fluoride activation of human lymphocyte adenylate cyclase is reduced in old age. Br J Clin Pharmacol (1982) 0.75
Role of neural influences in the release of gastrin, glucagon, and secretin during hypoglycaemia in man. Gut (1978) 0.75
Pharmacodynamics and pharmacokinetics of digoxin in the presence of lithium. Br J Clin Pharmacol (1984) 0.75
Evidence for a circulating sodium transport inhibitor in essential hypertension. Br Med J (Clin Res Ed) (1981) 0.75
Metabolism and disposition of intravenously administered acetyl-L-carnitine in healthy volunteers. Eur J Clin Pharmacol (1989) 0.75
The effect of digoxin on 86rubidium uptake by erythrocytes from mothers and babies. Br J Clin Pharmacol (1983) 0.75
Diminished activity of glyceryl trinitrate. Br Med J (Clin Res Ed) (1982) 0.75
Pharmacokinetics and haemodynamic effects of tocainide in patients with acute myocardial infarction complicated by left ventricular failure. Br J Clin Pharmacol (1985) 0.75
Plasma concentrations of drugs as a guide to therapy in clinical practice. Ir Med J (1978) 0.75
The efficacy of indapamide in hypertensive patients failing to respond to a beta-blocker alone. Methods Find Exp Clin Pharmacol (1984) 0.75
Biliary excretion and enterohepatic recirculation of practolol in man. Ir J Med Sci (1976) 0.75
Hospital emergency system expansion--make it part of the plans. Specif Eng (1985) 0.75
The kinetics of propranolol in hypothyroidism [proceedings]. Br J Clin Pharmacol (1980) 0.75
Perhexiline during exercise training in coronary heart disease. Clin Pharmacol Ther (1983) 0.75
Plasma protein binding of drugs in thyroid dysfunction [proceedings]. Br J Clin Pharmacol (1977) 0.75
Investigation of chronic dosing regimens of atenolol. Postgrad Med J (1977) 0.75
Altered lymphocyte beta-adrenoceptor function in the elderly [proceedings]. Br J Clin Pharmacol (1979) 0.75
Does ampicillin affect practolol kinetics? [proceedings]. Br J Clin Pharmacol (1977) 0.75
Antiarrhythmic and cardiovascular effects of MP 115. J Cardiovasc Pharmacol (1984) 0.75
Social support and efficacy in advocacy roles. A case study of two women's organizations. Issues Ment Health Nurs (1983) 0.75
The effect of chronic captopril therapy on platelet angiotensin II receptor density and vascular responsiveness to angiotensin II infusion. Eur J Clin Pharmacol (1987) 0.75
Estimation of concentrations of diltiazem in plasma using normal-phase column liquid chromatography with ultraviolet detection. J Chromatogr (1986) 0.75
Protein binding and disposition of lignocaine in the elderly. Eur J Clin Pharmacol (1985) 0.75
Toxicity testing in relation to aging. Arch Toxicol Suppl (1982) 0.75
Liquid chromatographic determination of paracetamol and dextropropoxyphene in plasma. J Chromatogr (1987) 0.75
Theophylline pharmacokinetics in respiratory viral illness. Lancet (1978) 0.75
Lack of effect of diazepam on the ST segment of the electrocardiogram during maximal exercise stress testing in normal subjects. J Cardiovasc Pharmacol (1980) 0.75
The mental health agent in the urban community. Rep Group Adv Psychiatry (1964) 0.75
The clinical pharmacology of vasodilator antihypertensive drugs. Arch Int Pharmacodyn Ther (1980) 0.75
Propranolol kinetics in hyperthyroidism [proceedings]. Br J Clin Pharmacol (1979) 0.75
The need to work together to succeed in breaking the nursing mould. Aust Nurses J (1984) 0.75
Staff stress in critical care units. Aust Health Rev (1988) 0.75
Community psychology: some priorities for the immediate future. J Community Psychol (1975) 0.75
Pharmacokinetics of lignocaine in the elderly [proceedings]. Br J Clin Pharmacol (1980) 0.75
A comparison of first and third year nursing students: role perception and expectations. Aust Nurses J (1983) 0.75
Stress and coping strategies in hospitals--a comparison of ICU and ward nurses. Aust Nurses J (1983) 0.75
Choice of selective versus nonselective beta blockers: implications for exercise training. Am J Cardiol (1985) 0.75
The 1984 Division 27 award for distinguished contributions to community psychology and community mental health: George Spivack and Myrna B. Shure. Am J Community Psychol (1985) 0.75
Social and community interventions. Annu Rev Psychol (1977) 0.75
Pharmacokinetics of amlodipine in renal impairment. J Cardiovasc Pharmacol (1988) 0.75